Advanced proteomic technologies for cancer biomarker discovery

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Proteomic technologies have significantly advanced, improving cancer patient diagnosis, prognosis, and treatment monitoring.
• These advancements enable the discovery of more sensitive and specific tumor markers.

Purpose of the Study:

• To review state-of-the-art proteomic technologies and their applications in cancer biomarker discovery.
• To highlight progress in proteomic technologies from 1997 to 2008.
• To discuss current challenges and future solutions in cancer biomarker research.

Main Methods:

• Review of four advanced proteomic technologies: 2D difference gel electrophoresis, MALDI imaging mass spectrometry, electron transfer dissociation mass spectrometry, and reverse-phase protein array.
• Examination of advancements and applications of these techniques in cancer biomarker discovery.

Main Results:

• Significant progress in proteomic technologies has been observed between 1997 and 2008.
• These technologies offer improved capabilities for identifying potential cancer biomarkers.

Conclusions:

• Key proteomic technologies show great promise for cancer biomarker discovery.
• Addressing challenges like dynamic protein range, protocol standardization, and biomarker validation is crucial for future progress.